Incannex Healthcare (IXHL) Cash from Investing Activities (2023 - 2026)
Incannex Healthcare (IXHL) posted Cash from Investing Activities of -$18000.0 for Q1 2026, down 350.0% sequentially from -$4000.0 in Q4 2025.
Incannex Healthcare (IXHL) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Cash from Investing Activities for 4 years, with the latest figure at -$18000.0 in Q1 2026.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$64000.0 (down 14.29% YoY) and the FY2025 annual result came in at -$8000.0, up 97.11% from the prior year.
- Cash from Investing Activities declined to -$18000.0 in Q1 2026 per IXHL's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $6000.0 in Q1 2024 and troughed at -$221000.0 in Q3 2023.
- A 4-year average of -$60444.4 and a median of -$32000.0 in 2023 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 118.75% in 2024, down 98.25% in 2024.
- Over 4 years, Cash from Investing Activities stood at -$59000.0 in 2023, then soared by 94.92% to -$3000.0 in 2024, then plunged by 33.33% to -$4000.0 in 2025, then plunged by 350.0% to -$18000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$18000.0, -$4000.0, and -$42000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | -18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,000.00 |
| Mar 31, 2026 | -18,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | -42,000.00 |
| Sep 30, 2025 | -42,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Sep 30, 2023 | -221,000.00 |
| Sep 30, 2023 | -221,000.00 |
| Jun 30, 2023 | -171,000.00 |
| Jun 30, 2023 | -171,000.00 |
| Mar 31, 2023 | -32,000.00 |
| Mar 31, 2023 | -32,000.00 |